CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Sampling of tissueWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (6)

Name (Synonyms) Correlation
drug670 Corticosteroid Wiki 0.71
drug1365 Lopinavir-Ritonavir Wiki 0.71
drug658 Convalescent plasma Wiki 0.25
drug2527 Tocilizumab Wiki 0.19
drug262 Azithromycin Wiki 0.17
drug1086 Hydroxychloroquine Wiki 0.10

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Unraveling the Mechanisms of Olfactory Dysfunction in COVID-19

In December 2019, a new coronavirus causing severe acute respiratory syndrome was described in Wuhan, China. This virus, later named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread worldwide and has been designated a pandemic by the World Health Organization. By the beginning of March 2020, several Ear, Nose, Throat societies raised awareness of a frequent association between coronavirus disease 2019 (COVID-19) and smell disorders. In the present study, the investigators wish to begin to understand the pathogenesis of anosmia in COVID-19.

NCT04445597 SARS-CoV 2 Diagnostic Test: Sampling of tissue

Primary Outcomes

Description: In the sampled tissues, the investigators will determine presence of SARS-CoV-2 by means of immunohistochemistry.

Measure: Prevalence of SARS-CoV-2 in the sampled tissue

Time: Immediately after death

No related HPO nodes (Using clinical trials)